Merus Presents Preclinical Data on Its Novel Bispecific Antibody MCLA-117 at European Hematology Association 2013
6/17/2013 8:56:07 AM
More...
|
SUPPRESTEM Consortium Led by Merus Receives $7.7 Million FP7 Grant From the European Union
5/28/2013 9:52:28 AM
More...
|
Merus Further Expands R&D Capacity
3/7/2013 11:13:41 AM
More...
|
Merus Achieves Milestone With Novartis AG (NVS) Option
2/7/2013 7:08:33 AM
More...
|
OcellO and Merus Sign Agreement for Screening Bispecific Cancer Antibodies
1/14/2013 11:05:46 AM
More...
|
Merus Selects Clinical Candidate for the Treatment of Acute Myeloid Leukemia (AML)
1/7/2013 11:54:22 AM
More...
|
Merus Appoints Setareh van Driel Shamsili as Chief Medical Officer
12/11/2012 11:45:16 AM
More...
|
Merus Announces the Full Validation of Its MeMo® Transgenic Mouse for Common Light Chain Human Antibodies
10/8/2012 10:59:48 AM
More...
|
Dutch Biotech Merus Raises €21.7 Million ($30.7 Million)
1/29/2010 6:42:50 AM
More...
|
Crucell N.V. (CRXL) And DSM Biologics Announce PER.C6 Licensing Agreement With Merus For Production Of Monoclonal Antibody Combinations
10/19/2005 5:11:43 PM
More...
|